149 related articles for article (PubMed ID: 35440040)
1. Epigenetic and genomic profiling of chordoid meningioma: implications for clinical management.
Daoud EV; Zhu K; Mickey B; Mohamed H; Wen M; Delorenzo M; Tran I; Serrano J; Hatanpaa KJ; Raisanen JM; Snuderl M; Cai C
Acta Neuropathol Commun; 2022 Apr; 10(1):56. PubMed ID: 35440040
[TBL] [Abstract][Full Text] [Related]
2. Genomic analysis of spinal meningiomas: correlation with histopathological grade.
Driver J; Santagata S; Bi WL; Chi JH
J Neurosurg Spine; 2023 Dec; 39(6):729-733. PubMed ID: 37728381
[TBL] [Abstract][Full Text] [Related]
3. Favorable Long-Term Outcomes of Chordoid Meningioma Compared With the Other WHO Grade 2 Meningioma Subtypes.
Ren L; Hua L; Deng J; Cheng H; Wang D; Chen J; Xie Q; Wakimoto H; Gong Y
Neurosurgery; 2023 Apr; 92(4):745-755. PubMed ID: 36512828
[TBL] [Abstract][Full Text] [Related]
4. [Meningioma].
Sasaki H
No Shinkei Geka; 2023 Sep; 51(5):829-836. PubMed ID: 37743334
[TBL] [Abstract][Full Text] [Related]
5. Atypical meningiomas compared to other WHO Grade 2 meningiomas: Histological features and prognosis.
Ajlan A; Almeshari S; Basindwah S; Aljohani M; Alharbi Y; Aldhowaihy F; Alkhaldi H; Alqurashi A
Neurosciences (Riyadh); 2024 May; 29(2):96-102. PubMed ID: 38740393
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2 meningiomas.
Ehret F; Perez E; Teichmann D; Meier S; Geiler C; Zeus C; Franke H; Roohani S; Wasilewski D; Onken J; Vajkoczy P; Schweizer L; Kaul D; Capper D
Acta Neuropathol Commun; 2024 May; 12(1):74. PubMed ID: 38720399
[TBL] [Abstract][Full Text] [Related]
7. Intraventricular Meningiomas: Clinical-Pathological and Genetic Features of a Monocentric Series.
Ammendola S; Simbolo M; Ciaparrone C; Rizzo PC; Caffo M; Pinna G; Sala F; Scarpa A; Barresi V
Curr Oncol; 2022 Jan; 29(1):178-185. PubMed ID: 35049691
[TBL] [Abstract][Full Text] [Related]
8. Atypical meningioma: Histopathological, genetic, and epigenetic features to predict recurrence risk.
Marastoni E; Barresi V
Histol Histopathol; 2024 Mar; 39(3):293-302. PubMed ID: 37921468
[TBL] [Abstract][Full Text] [Related]
9. Clinical and genomic differences in supratentorial versus infratentorial NF2 mutant meningiomas.
Tabor JK; O'Brien J; Vasandani S; Vetsa S; Lei H; Jalal MI; Marianayagam NJ; Jin L; Millares Chavez M; Haynes J; Dincer A; Yalcin K; Aguilera SM; Omay SB; Mishra-Gorur K; McGuone D; Morales-Valero SF; Fulbright RK; Gunel M; Erson-Omay EZ; Moliterno J
J Neurosurg; 2023 Dec; 139(6):1648-1656. PubMed ID: 37243548
[TBL] [Abstract][Full Text] [Related]
10. Infarction with associated pseudosarcomatous changes mimics anaplasia in otherwise grade I meningiomas.
Bale TA; Benhamida J; Roychoudury S; Villafania L; Wrzolek MA; Bouffard JP; Bapat K; Ladanyi M; Rosenblum MK
Mod Pathol; 2020 Jul; 33(7):1298-1306. PubMed ID: 32047229
[TBL] [Abstract][Full Text] [Related]
11. Mutation Status and Epithelial Differentiation Stratify Recurrence Risk in Chordoid Meningioma-A Multicenter Study with High Prognostic Relevance.
Georgescu MM; Nanda A; Li Y; Mobley BC; Faust PL; Raisanen JM; Olar A
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31963394
[TBL] [Abstract][Full Text] [Related]
12. [Classification and Molecular Diagnosis of Benign Brain Tumors].
Yoshimoto K
No Shinkei Geka; 2023 Sep; 51(5):771-777. PubMed ID: 37743328
[TBL] [Abstract][Full Text] [Related]
13. Meningioma: current updates on genetics, classification, and mouse modeling.
Szulzewsky F; Thirimanne HN; Holland EC
Ups J Med Sci; 2024; 129():. PubMed ID: 38571886
[TBL] [Abstract][Full Text] [Related]
14. Rare case of extracranial chordoid meningioma adjacent to the carotid sheath: illustrative case.
Jeong SW; Moran M; Elhamdani S; Kusyk DM; Xu C; Gyure K; Williamson R
J Neurosurg Case Lessons; 2023 Jan; 5(4):. PubMed ID: 36692061
[TBL] [Abstract][Full Text] [Related]
15. Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma.
Olar A; Wani KM; Wilson CD; Zadeh G; DeMonte F; Jones DT; Pfister SM; Sulman EP; Aldape KD
Acta Neuropathol; 2017 Mar; 133(3):431-444. PubMed ID: 28130639
[TBL] [Abstract][Full Text] [Related]
16. Genomic markers of recurrence risk in atypical meningioma following gross total resection.
Vaubel RA; Kumar R; Weiskittel TM; Jenkins S; Dasari S; Uhm JH; Lachance DH; Brown PD; Van Gompel JJ; Jenkins RB; Kipp BR; Sukov WR; Giannini C; Johnson DR; Raghunathan A
Neurooncol Adv; 2023; 5(1):vdad004. PubMed ID: 36845294
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy and targeted therapies for meningiomas: what is the evidence?
Graillon T; Tabouret E; Chinot O
Curr Opin Neurol; 2021 Dec; 34(6):857-867. PubMed ID: 34629433
[TBL] [Abstract][Full Text] [Related]
18. Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets.
Maggio I; Franceschi E; Di Nunno V; Gatto L; Tosoni A; Angelini D; Bartolini S; Lodi R; Brandes AA
Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679551
[TBL] [Abstract][Full Text] [Related]
19. CDKN2A/B deletions are strongly associated with meningioma progression: a meta-analysis of individual patient data.
Wach J; Basaran AE; Arlt F; Vychopen M; Seidel C; Barrantes-Freer A; Müller W; Gaunitz F; Güresir E
Acta Neuropathol Commun; 2023 Nov; 11(1):189. PubMed ID: 38017560
[TBL] [Abstract][Full Text] [Related]
20. Meningioma: Molecular Updates from the 2021 WHO Classification of CNS Tumors and Imaging Correlates.
Soni N; Ora M; Bathla G; Szekeres D; Desai A; Pillai J; Agarwal A
AJNR Am J Neuroradiol; 2024 Jun; ():. PubMed ID: 38844366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
